Alterity Therapeutics (ATHE) Cash from Operations (2009 - 2020)
Alterity Therapeutics (ATHE) posted quarterly Cash from Operations of 6181351.89 for Q2 2020, up 36.76% year-over-year from 4519740.49 in Q3 2019, and down 449.93% quarter-over-quarter from 1766470.98 in Q4 2019.
Alterity Therapeutics (ATHE) Cash from Operations (2009 - 2020) Analysis & Trends
Alterity Therapeutics' Cash from Operations history runs 9 years deep, the most recent figure standing at 6181351.89 for Q2 2020.
- In Q2 2020, Cash from Operations rose 36.76% year-over-year to 6181351.89; the TTM figure through Jun 2020 stood at 19370713.16 (down 21.79% YoY), while the FY2025 annual figure was 7333759.44, up 11.72% from the prior year.
- Cash from Operations for Q2 2020 stood at 6181351.89, down from 1766470.98 in the prior quarter.
- The five-year high for Cash from Operations was 1766470.98 in Q4 2019, with the low at 9774963.11 in Q2 2019.
- The 5-year median for Cash from Operations is 4405908.68 (2017), against an average of 3414551.96.
- Peak annual rise in Cash from Operations reached 134.1% in 2019, while the deepest fall reached 20575.33% in 2019.
- Alterity Therapeutics' Cash from Operations stood at 465813.11 in 2016, then plunged by 93.6% to 901823.06 in 2017, then slumped by 474.49% to 5180869.14 in 2018, then surged by 134.1% to 1766470.98 in 2019, then tumbled by 449.93% to 6181351.89 in 2020.
- Business Quant data shows ATHE's Cash from Operations at 6181351.89 in Q2 2020, 1766470.98 in Q4 2019, and 9774963.11 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Alterity Therapeutics | 48.56 Mn | 16.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -6.18 Mn |
| Jun 30, 2020 | -6.18 Mn |
| Dec 31, 2019 | 1.77 Mn |
| Dec 31, 2019 | 1.77 Mn |
| Jun 30, 2019 | -9.77 Mn |
| Jun 30, 2019 | -9.77 Mn |
| Dec 31, 2018 | -5.18 Mn |
| Dec 31, 2018 | -5.18 Mn |
| Jun 30, 2018 | -47,278.38 |
| Jun 30, 2018 | -47,278.38 |
| Dec 31, 2017 | -901,823.06 |
| Dec 31, 2017 | -901,823.06 |
| Jun 30, 2017 | -4.41 Mn |
| Jun 30, 2017 | -4.41 Mn |
| Dec 31, 2016 | -465,813.11 |
| Dec 31, 2016 | -465,813.11 |
| Jun 30, 2016 | -5.54 Mn |
| Jun 30, 2016 | -5.54 Mn |
| Jun 30, 2012 | -6,916.69 Bn |
| Jun 30, 2012 | -6,916.69 Bn |